Anne Walker1,2, Matthew T Naughton3,4, Lachlan Shaw4, Andrew T Jeklin4, Catherine Martin5, Eli Dabscheck3,4. 1. Department of Thoracic Medicine, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, Australia. 2. University of Adelaide, Adelaide, Australia. 3. Department of Respiratory Medicine, Alfred Health, Melbourne, Australia. 4. School of Medicine, Monash University, Victoria, Melbourne, Australia. 5. Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia.
Abstract
STUDY OBJECTIVES: To assess changes in Hospital Anxiety and Depression Scale (HADS) scores after continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea. METHODS: Consecutive patients attending the Alfred Health sleep clinic, diagnosed with obstructive sleep apnea, and prescribed CPAP were recruited. The primary outcome was a change in the HADS depression (HADS-D) and anxiety (HADS-A) subscales from the time of diagnosis to follow-up. Secondary analysis compared high (> 4 hours) and low (< 4 hours) CPAP adherence groups and change in depression cases, defined by HADS-D ≥ 8, and anxiety cases, defined by HADS-A ≥ 11. RESULTS: We included 108 participants in the final analysis. Adherence groups were well matched in baseline mood, sleepiness, and apnea variables. Overall age (mean ± standard deviation) was 56.1 ± 12.8 years, and there was a median (interquartile ratio) apnea-hypopnea-index of 42.7 (27.5-58.1) or median (interquartile ratio) oxygen-desaturation-index of 43.0 (26.0-74.0). The median duration of CPAP therapy was 1.3 years. The HADS-D decreased after CPAP by -1.4 (adjusted 95% confidence interval, -2.1 to -0.6; P = .001). Patients with high-CPAP adherence (n = 84) had a tendency towards a greater reduction in HADS-D (-1.5) compared with those with low-CPAP adherence (n = 24; -0.3; adjusted P = .19). Depression cases (HADS-D ≥ 8) decreased by 13.1% in the high-CPAP-adherence group (P = .03) and increased by 4.1% in the low-CPAP-adherence group (P = .71). The HADS-A decreased after CPAP by -1.8 (adjusted 95% confidence interval, -1.8 to -0.4; P = .004). There was no significant difference between adherence groups or anxiety cases (HADS-A > 11). CONCLUSIONS: Specialized obstructive sleep apnea treatment with CPAP reduces depression scores, with a trend toward greater reduction in those with high CPAP adherence.
STUDY OBJECTIVES: To assess changes in Hospital Anxiety and Depression Scale (HADS) scores after continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea. METHODS: Consecutive patients attending the Alfred Health sleep clinic, diagnosed with obstructive sleep apnea, and prescribed CPAP were recruited. The primary outcome was a change in the HADS depression (HADS-D) and anxiety (HADS-A) subscales from the time of diagnosis to follow-up. Secondary analysis compared high (> 4 hours) and low (< 4 hours) CPAP adherence groups and change in depression cases, defined by HADS-D ≥ 8, and anxiety cases, defined by HADS-A ≥ 11. RESULTS: We included 108 participants in the final analysis. Adherence groups were well matched in baseline mood, sleepiness, and apnea variables. Overall age (mean ± standard deviation) was 56.1 ± 12.8 years, and there was a median (interquartile ratio) apnea-hypopnea-index of 42.7 (27.5-58.1) or median (interquartile ratio) oxygen-desaturation-index of 43.0 (26.0-74.0). The median duration of CPAP therapy was 1.3 years. The HADS-D decreased after CPAP by -1.4 (adjusted 95% confidence interval, -2.1 to -0.6; P = .001). Patients with high-CPAP adherence (n = 84) had a tendency towards a greater reduction in HADS-D (-1.5) compared with those with low-CPAP adherence (n = 24; -0.3; adjusted P = .19). Depression cases (HADS-D ≥ 8) decreased by 13.1% in the high-CPAP-adherence group (P = .03) and increased by 4.1% in the low-CPAP-adherence group (P = .71). The HADS-A decreased after CPAP by -1.8 (adjusted 95% confidence interval, -1.8 to -0.4; P = .004). There was no significant difference between adherence groups or anxiety cases (HADS-A > 11). CONCLUSIONS: Specialized obstructive sleep apnea treatment with CPAP reduces depression scores, with a trend toward greater reduction in those with high CPAP adherence.
Authors: Nicola Canessa; Vincenza Castronovo; Stefano F Cappa; Mark S Aloia; Sara Marelli; Andrea Falini; Federica Alemanno; Luigi Ferini-Strambi Journal: Am J Respir Crit Care Med Date: 2010-10-29 Impact factor: 21.405
Authors: Dionne E Smid; Frits M E Franssen; Sarah Houben-Wilke; Lowie E G W Vanfleteren; Daisy J A Janssen; Emiel F M Wouters; Martijn A Spruit Journal: J Am Med Dir Assoc Date: 2016-09-10 Impact factor: 4.669
Authors: Terri E Weaver; Cristina Mancini; Greg Maislin; Jacqueline Cater; Bethany Staley; J Richard Landis; Kathleen A Ferguson; Charles F P George; David A Schulman; Harly Greenberg; David M Rapoport; Joyce A Walsleben; Teofilo Lee-Chiong; Indira Gurubhagavatula; Samuel T Kuna Journal: Am J Respir Crit Care Med Date: 2012-07-26 Impact factor: 21.405
Authors: Nick A Antic; Catherine Buchan; Adrian Esterman; Michael Hensley; Matthew T Naughton; Sharn Rowland; Bernadette Williamson; Samantha Windler; Simon Eckermann; R Doug McEvoy Journal: Am J Respir Crit Care Med Date: 2009-01-08 Impact factor: 21.405
Authors: Romola S Bucks; Shenooka Nanthakumar; Sergio S Starkstein; David R Hillman; Alan James; Nigel McArdle; Katherine Hatch; Timothy C Skinner Journal: Sleep Date: 2018-12-01 Impact factor: 5.849